经皮真空辅助旋切术治疗恶性潜能不确定的乳腺病变(B3类病变)作为开放手术活检替代方案的有效性
这项回顾性研究在两家中心纳入2017年1月至2019年12月诊断的258个B3乳腺病变,其中105个符合条件并接受真空辅助旋切术(VAE)。VAE后8.6%(9/105)升级为恶性,伴上皮异型的B3病变恶性检出率为15.5%(9/58),而无异型者为0%(0/47),差异有统计学意义(p=.004)。作者认为VAE是B3病变管理的替代方法,可减少开放手术。
要点
- B3病变VAE后恶性升级率8.6%(9/105),升级与初始活检伴上皮异型相关。
- 伴上皮异型B3病变恶性检出率15.5%(9/58),无异型者为0%(0/47),p=.004。
- 平均乳腺X线随访2.2年,VAE部位未见新病变或恶性肿瘤。
核心结论
- VAE后恶性升级不常见(8.6%),且与初始活检存在异型相关;VAE是B3病变管理的替代方法,可减少开放手术。
研究设计与样本
- 回顾性研究,在两家中心纳入2017年1月至2019年12月诊断的258个B3病变,其中105个(40.7%)符合纳入标准并接受VAE;VAE在X线引导(89/105)或超声引导(16/105)下进行,使用10-G针平均取材18.5条,或7-G针平均取材10.8条;最终是否行VAE均由多学科会议(MDM)决定。
诊断标准与关键数值
- VAE后9例(8.6%)升级为恶性诊断;伴上皮异型的B3病变恶性检出率为15.5%(9/58),无异型的B3病变为0%(0/47),风险差异检验p=.004。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Traditionally B3 breast lesions are treated surgically, but overtreatment is a concern, as the majority have a final benign diagnosis. A national screening program introduced vacuum-assisted excision (VAE) for managing B3 lesions in late 2016. This retrospective study aimed to assess the outcomes associated with this approach.
METHODS: All B3 lesions diagnosed between 01/2017 and 12/2019 were identified at two centres. Information was obtained on the initial biopsy and final histology, and method of VAE image guidance, needle size and number of cores. Lesions were excluded if there was cancer elsewhere in the breast at the time of diagnosis; the lesion was not suitable for VAE due to position in the breast or had B3 pathology for which open biopsy was still required. The final decision to offer VAE was always made at a multidisciplinary meeting (MDM). Risk difference was used to test the significance at p ≤ .05.
RESULTS: In total, 258 B3 lesions were diagnosed, 105 (40.7%) met the inclusion criteria and underwent VAE. VAE was performed under X-ray (89/105) or ultrasound guidance (16/105), taking an average of 18.5 cores with the 10-G needle or 10.8 cores with the 7-G needle. Nine cases (8.6%) were upgraded to a malignant diagnosis following VAE. Malignancy was found in 15.5% (9/58) of B3 lesions with epithelial atypia, but in none without atypia (0/47) (p = .004). No new lesions or malignancy has occurred at the site of the VAE with an average mammographic follow-up of 2.2 years.
CONCLUSION: Upgrade to malignancy following VAE was uncommon (8.6%) and associated with atypia in the initial biopsy. VAE is an alternative approach to the management of B3 lesions, reducing open surgical procedures.
KEY POINTS: • Upgrade to malignancy after a vacuum-assisted excision of a B3 breast lesion is uncommon with an 8.6% upgrade rate. • The risk of a malignant diagnosis after a vacuum-assisted excision was significantly higher for B3 lesions with atypia compared to those without (+15.5% difference, p = .004).
引用
- Giannotti E, James JJ, Chen Y, et al. Effectiveness of percutaneous vacuum-assisted excision (VAE) of breast lesions of uncertain malignant potential (B3 lesions) as an alternative to open surgical biopsy. Eur Radiol. 2021. PMID: 34100998. doi:10.1007/s00330-021-08060-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。